Chesnara (LON:CSN - Get Free Report) released its quarterly earnings results on Tuesday. The company reported GBX 0.22 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Chesnara had a return on equity of 0.25% and a net margin of 0.04%.
Here are the key takeaways from Chesnara's conference call:
- H1 2026 operating capital generation rose 79% to £96 million, while cash remittances increased 31% to £73 million. The performance supported a 6% increase in the interim dividend to 8.16 pence per share.
- Chesnara Life UK, acquired from HSBC in January, contributed £51 million of operating capital generation and £20 million of cash remittances in its first five months. Integration is progressing, with data migration from HSBC remaining on track for completion by the end of 2026.
- The balance sheet remains strong, with the Solvency II coverage ratio at 185%, above the 180% pro forma estimate and the company’s 140%-160% target range. This leaves capacity for further acquisitions, with management estimating roughly £130 million of immediate transaction headroom plus additional debt capacity.
- Future value increased materially, with assets under administration reaching £21 billion and the Contractual Service Margin rising from £131 million to £327 million following the Chesnara Life acquisition. Management expects 2026 new-business value to be approximately double the prior year, although M&A is expected to remain the primary growth driver.
- Sweden experienced adverse persistency and lapse trends, as outflows from higher-margin existing business exceeded inflows despite strong net client cash flows, a new Norway partnership and approximately £700 million of additional assets under administration. Dutch mortality was also adverse in Q1, though management characterized it as seasonal and said experience reverted toward its long-term average in Q2.
Chesnara Stock Up 4.7%
Shares of CSN stock traded up GBX 17 during mid-day trading on Friday, reaching GBX 376. 2,207,848 shares of the stock traded hands, compared to its average volume of 1,071,456. The company has a market cap of £867.44 million, a price-to-earnings ratio of -74.46 and a beta of 0.52. The stock's fifty day simple moving average is GBX 336.99 and its two-hundred day simple moving average is GBX 320.51. Chesnara has a 1-year low of GBX 264.58 and a 1-year high of GBX 376.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on CSN. Berenberg Bank increased their price objective on shares of Chesnara from GBX 404 to GBX 437 and gave the stock a "buy" rating in a research note on Wednesday. Royal Bank Of Canada boosted their target price on shares of Chesnara from GBX 360 to GBX 400 and gave the company an "outperform" rating in a research report on Thursday. Two investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has an average rating of "Buy" and a consensus target price of GBX 418.50.
Check Out Our Latest Analysis on Chesnara
Insider Activity at Chesnara
In related news, insider Steve Murray acquired 13,102 shares of the firm's stock in a transaction that occurred on Tuesday, August 25th. The stock was acquired at an average cost of GBX 342 per share, for a total transaction of £44,808.84. Also, insider Tom Howard acquired 14,490 shares of the firm's stock in a transaction that occurred on Tuesday, August 25th. The stock was bought at an average price of GBX 343 per share, with a total value of £49,700.70. Insiders bought 29,045 shares of company stock valued at $9,947,880 in the last ninety days. 0.87% of the stock is currently owned by insiders.
Chesnara Company Profile
(
Get Free Report)
Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.
Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests.
Further Reading

Before you consider Chesnara, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chesnara wasn't on the list.
While Chesnara currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.